<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">503</article-id><article-id pub-id-type="doi">10.36691/RJA503</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Efficiency and safety of levoсabastine (TYZINE®ALERGY) in allergic rhinitis patients</article-title><trans-title-group xml:lang="ru"><trans-title>Систематизированное клиническое наблюдение об эффективности и безопасности левокабастина (ТИЗИН®АЛЕРДЖИ) у больных с аллергическим ринитом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Elisyutina</surname><given-names>O G</given-names></name><name xml:lang="ru"><surname>Елисютина</surname><given-names>Ольга Гурьевна</given-names></name></name-alternatives><email>el-olga@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shtyrbul</surname><given-names>O V</given-names></name><name xml:lang="ru"><surname>Штырбул</surname><given-names>О В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ilina</surname><given-names>N I</given-names></name><name xml:lang="ru"><surname>Ильина</surname><given-names>Н И</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Institute of Immunology</institution></aff><aff><institution xml:lang="ru">ФГБУ «ГНЦ Институт иммунологии» ФМБА России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2015-02-15" publication-format="electronic"><day>15</day><month>02</month><year>2015</year></pub-date><volume>12</volume><issue>1</issue><issue-title xml:lang="en">NO1 (2015)</issue-title><issue-title xml:lang="ru">№1 (2015)</issue-title><fpage>65</fpage><lpage>72</lpage><history><date date-type="received" iso-8601-date="2020-03-10"><day>10</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2015, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2015, Фармарус Принт Медиа</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2017-12-15"/></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/503">https://rusalljournal.ru/raj/article/view/503</self-uri><abstract xml:lang="en"><p>Own results of clinical observation about application of levoсabastine in complex therapy of allergic rhinitis are presented in the article</p></abstract><trans-abstract xml:lang="ru"><p>В статье представлены собственные результаты клинического наблюдения о применении левокабастина в комплексной терапии аллергического ринита.</p></trans-abstract><kwd-group xml:lang="en"><kwd>allergic rhinitis</kwd><kwd>H -blockers</kwd><kwd>levocabastine</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>аллергический ринит</kwd><kwd>Н -блокаторы</kwd><kwd>левокабастин</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Аллергология. Федеральные клинические рекомендации. Под ред. Р.М. Хаитова, Н.И. Ильиной. M., «Фармарус Принт Медиа». 2014, 126 с.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Bousquet J., Khaltaev N., Cruz A.A. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008, v. 86, p. 8-160.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Falser N., Wober W., Rahlfs V.W., Baehre M. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis. Arzneimittelforschung. 2001, v. 51, p. 387-393.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Canonica W.G., Marzetto M., Kolb С., Ellers-Lenz B. Multinational clinical trial to assess efficacy and safety of azelastine eye drops in patients with perennial allergic conjunctivitis/rhino-conjunctivitis. Annual Meeting of the European Academy of Allergology and Clinical Immunology. 2000, p. 662.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Kremer B., Tündermannb A., Goldschmidt O. et al. Effectiveness and Tolerance of Levocabastine and Nedocromil in Topical Therapy of Seasonal Allergic Rhinoconjunctivitis. Armeim. Forsch. Drug. Res. 1998, v. 48, p. 924-930.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Gerth van Wijk R. Treatment of allergic rhinoconjunctivitis a review of the role of topical levocabastine. Mediators of Inflammation. 1995, v. 4, p. 31-38.</mixed-citation></ref></ref-list></back></article>
